Examples of 'anti-ige' in a sentence
Meaning of "anti-ige"
Anti-ige is a noun that may refer to a substance or treatment that works against immunoglobulin E, a type of antibody involved in allergic reactions
How to use "anti-ige" in a sentence
Basic
Advanced
anti-ige
Adsorption of anti-IgE antibodies on a polystyrene plate.
The IgE suppressor is an anti-IgE antibody.
Preferably the anti-IgE antibody of the invention is a human or humanised antibody.
Mix twice following addition of the anti-IgE.
The side effects of Anti-IgE are low to moderate.
This establishes whether or not they are non-anaphylactogenic anti-IgE antibodies.
Figure 3 depicts analysis of an anti-IgE monoclonal antibody by capillary electrophoresis.
Hydrophobic interaction chromatography of a pepsin digested anti-IgE monoclonal antibody.
Effect of anti-IgE antibodies on histamine release of sensitized bone marrow cells.
The bispecific antibody may have an anti-IgE specificity.
Treatment with anti-IgE gave the expected result of no detectable IgE.
Test sample reacts with gold labeled anti-IgE antibody.
The anti-IgE antibodies of the invention are preferably administered via mucosal route.
The cells were then stimulated with anti-IgE antibody as previously described.
The anti-IgE may be prepared and isolated according to well known techniques.
See also
Thus, one type of downregulator of IgE is an anti-IgE antibody or antibody fragment.
The blanks have cells and all reagents except antigen or anti-IgE.
Administering and-FceRI or anti-IgE antibodies activates basophils and mast cells.
Hydrophobic interaction chromatography analyses of papain digested anti-IgE monoclonal antibody.
Thus, patients receiving anti-IgE antibody had reduced hyperresponsiveness as a result of therapy.
In a more specific embodiment, the labeled reagent comprises labeled anti-IgE antibody.
More preferably, the anti-IgE antibodies of the invention are administered via sublingual route.
A preferred antibody composition of the disclosure includes recombinant humanized anti-IgE antibodies.
The capacity of the anti-IgE therapy to decrease FceRI expression has been demonstrated on basophils.
Each dot plot corresponds to the stimulation of whole blood by decreasing concentrations of anti-IgE.
These results also demonstrate that the anti-IgE responses are reversible and repeatable.
Another treatment form of allergies involves the intravenous injection of monoclonal anti-IgE antibodies.
In another embodiment, the invention relates to an anti-IgE antibody having improved affinity to IgE.
The invention provides a polynucleotide in which the selected sequences encode a anti-IgE antibody.
The anti-IgE therapeutic concept was not well received in the early period of the program.
The method of claim 1 wherein the IgE antagonist is an anti-IgE antibody or fragment thereof.
A suitable anti-IgE antibody is omalizumab, a recombinant humanized monoclonal antibody commonly used in anti-IgE therapy.
In a further preferred embodiment, the antibody is anti-IgE and the target molecule is IgE.
The second incubation is again followed by several washing steps to remove non-bound labeled anti-IgE.
This may be carried out using an anti-IgE antibody that is enhanced for effector function.
Some evolving therapies for treating or preventing allergy include the use of neutralizing anti-IgE antibodies.
Humanized anti-IgE monoclonal antibodies are described in Presta et al.
Allergic asthma and rhinitis anti-IgE.
Anti-IgE for chronic asthma in adults and children.
Other drugs include an anti-IgE binding-antibody.
Two anti-IgE antibodies made in CHO cells were used as controls.
In one embodiment, the downregulator of IgE is an anti-IgE.
Anti-IgE might be used if other asthma medicines have not worked well.
One example is an anti-IgE antibody.
Anti-IgE antibody fragments can also be used in the methods of the invention.
In case IgG antibodies are to be determined anti-IgG replaces anti-IgE.
Anti-IgE antibodies of the invention preferably have high affinity for FcYRIIb.
The method of claim 2 wherein the antibody is a humanized anti-IgE antibody.
Anti-IgE therapy disrupts the sequence of events that causes an allergic reaction.
This phenomenon was e.g. seen in paradoxic IgE increase after anti-IgE treatment.
